SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Becton, Dickinson and Company BDXB NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Becton, Dickinson and Company (BDXB) 是一家 Medical - Instruments & Supplies 公司，属于医疗保健行业, 目前交易价格为 $48.16. 其SharesGrow评分为 64/100, 表明高于平均的投资特征， 7项中通过3项.

财务数据: 营收为 $21.8B, +5%/yr 平均增长. 净利润为 $1.7B, 增长率为 -1.1%/yr. 净利润率为 7.7% (较薄). 毛利率为 45.4% (+0.5 pp 趋势).

资产负债表: 总债务为 $19.2B 对比 $25.4B 股东权益 (D/E比率 0.76, 适度). 流动比率为 1.11 (充足). 资产负债率为 34.7%. 总资产: $55.3B.

分析师展望: 16 / 30 位分析师评级 BDXB 为买入 (53%) — 适度共识.

SharesGrow 7项标准细分: Value 100/100 (Pass), Growth 40/100 (Partial), Past 100/100 (Pass), Health 50/100 (Partial), Moat 73/100 (Pass), Future 40/100 (Partial), Income 45/100 (Partial).

BDXB SharesGrow 评分概览

64/100

SharesGrow Score

Above average fundamentals

View full scorecard →

价值 100/100

估值 — P/E, PEG, Forward PEG

成长 40/100

财务数据 — 平均增长

过去 100/100

强劲 — 趋势

健康 50/100

资产负债表 — D/E比率, 流动比率为

护城河 73/100

毛利率为 + market cap

未來 40/100

分析师展望 — 为买入

收入 45/100

净利润率为

Scores derived from financial statements, analyst ratings, and balance sheet data.

评分明细 — BDXB

BDXB 市盈率(P/E)为 N/A (S&P 500平均约25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上涨空间 (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

BDXB: +5%/yr 营收为, -1.1%/yr 净利润为平均增长. 一般. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

BDXB: 4 / 4 年盈利. 强劲 — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

资产负债表 BDXB: D/E比率 0.76 (适度), 流动比率为 1.11 (充足). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

BDXB: 毛利率为 45.4% (+0.5 pp 趋势), $14B market cap. Moat (0-100): margin (35%) + 趋势 (15%) + market cap (30%) + 营收为 (20%). Score 73/100. ≥ 70 = Pass.

View details →

分析师展望: 16 / 30 位分析师评级 BDXB 为买入 (53%). Score: 60% buy consensus + 40% 上涨空间. ≥ 60 = Pass.

View details →

BDXB: 净利润率为 7.7%. 较薄 (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

股票图表与统计

市场数据

52周区间45.85-52.52

成交量2.76M

30日平均成交量449.58K

市值$13.69B

Beta（1年）0.56

股息率$3.0000

股份统计

EPS（TTM）5.84

流通股数$286.61M

IPO日期2020-05-21

员工数77,000

首席执行官Thomas E. Polen Jr.

财务亮点与比率

营收（TTM）$21.84B

毛利润$9.92B

EBITDA$4.96B

净利润$1.68B

营业利润$2.58B

现金总额$859M

总负债$19.18B

净负债$18.33B

总资产$55.33B

市盈率（P/E）8.2

市销率（P/S）0.63

分析师预测

评级共识Buy

覆盖分析师数30

买入 53% 持有 43% 卖出 3%

公司信息

国家US

交易所NYSE

货币USD

ISINUS0758874061

股价走势

BDXB

Becton, Dickinson and Company ↗ · NYSE

Healthcare • Medical - Instruments & Supplies

45.85 52周区间 52.52

其他人也在看

Boston Scientific Corporation

Brighthouse Financial, Inc.

Brighthouse Financial, Inc.

Brighthouse Financial, Inc.

American Electric Power Company, Inc.

Eli Lilly and Company

Johnson & Johnson

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言